OTC regulatory body reviews ad regulations

August 2002
Marketing Week;8/15/2002, Vol. 25 Issue 33, p8
Trade Publication
Reports on planned revision of the advertising code of the Proprietary Association of Great Britain, the trade body for over-the-counter (OTC) medicines and food supplements. Switch of medicines from being prescription-only medicine to OTC; Regulation of the use of celebrities' endorsement for OTC and the use of medical jargon in advertising.


Related Articles

  • FDA policy spurs consumer TV drug ads. Wechsler, Jill // Managed Healthcare;Oct97, Vol. 7 Issue 10, p12 

    Focuses on the impact of US Food and Drug Administration's plans to modify its policy governing direct-to-consumer broadcast advertising of prescription drugs. New ad campaigns from marketers; Concern about unwarranted patient demand for what might be inappropriate therapies; Broad...

  • Just ask your doctor. Surman, Matt // Adweek Western Edition;9/9/96, Vol. 46 Issue 37, p12 

    Reports on the regulatory battle involving direct-to-consumer pharmaceutical advertising in the United States. Background on the requirements set by the Food and Drug Administration's (FDA) for advertising pharmaceuticals; Efforts of agencies and advertisers to change the rule; Notice published...

  • An anti-drug search. FitzGerald, Nora // Adweek Western Edition;08/18/97, Vol. 47 Issue 33, p6 

    Provides information on the $150 million anti-drug campaign being launched by the federal government in the United States. Comments from Don Maple, deputy director of public affairs at the Drug Control Policy office; Who the campaign will be aimed primarily at.

  • Washington letter.  // DCI;Apr94, Vol. 154 Issue 4, p10 

    Reports on the lack of astonishment at the Generic Pharmaceutical Industry Association's praise of the Clinton administration for its health care proposal.

  • Washington letter.  // DCI;May94, Vol. 154 Issue 5, p10 

    Reports that the Nonprescription Drug Manufacturers Association has asked the Food and Drug Administration to abandon the effective date for unsealed hard gelatin capsules.

  • Washington letter.  // DCI;Jun94, Vol. 154 Issue 6, p10 

    Reports on Pharmaceutical Manufacturers Association's changing of its name to Pharmaceutical Research & Manufacturers of America in an effort to distance itself from the generic drug industry. Focus of the association on drug research; Association's effort to fight generic prescribing;...

  • PMA changes name and focus to stress its research roots. Conlan, Michael F. // Drug Topics;5/23/94, Vol. 138 Issue 10, p62 

    Reports that the Pharmaceutical Manufacturers Association has changed its name to the Pharmaceutical Research and Manufacturers of America (PhRMA). Highlights of PhRMA's annual meeting; Appointment of Stephen R. Conafy as the vice president of strategic and legislative affairs; Expansion of the...

  • Associations discuss merger possibility.  // Drug Topics;9/4/95, Vol. 139 Issue 17, p7 

    Reports that leaders of the American Managed Care Pharmacy Association and the Academy of Managed Care Pharmacy have discussed the possibility of merging.

  • Drug firms boost R&D spending.  // R&D Magazine;Feb94, Vol. 36 Issue 2, p19 

    Reports on the increase in research and development in 1993 by members of the Pharmaceutical Manufacturers Association.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics